Allelic drop-out may occur with a primer binding site polymorphism for the commonly used RFLP assay for the -1131T>C polymorphism of the Apolipoprotein AV gene by Ward, Kirsten J et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Lipids in Health and Disease
Open Access Research
Allelic drop-out may occur with a primer binding site 
polymorphism for the commonly used RFLP assay for the -1131T>C 
polymorphism of the Apolipoprotein AV gene
Kirsten J Ward1, Sian Ellard1, Chittaranjan S Yajnik2, Timothy M Frayling1, 
Andrew T Hattersley*1, Prathyusha NS Venigalla3 and Giriraj R Chandak3
Address: 1Institute of Biomedical and Clinical Science, Peninsula Medical School, Exeter, UK, 2Diabetes Unit, King Edward Memorial Hospital and 
Research Centre, Pune, India and 3Genome Research Group, Centre for Cellular and Molecular Biology, Hyderabad, India
Email: Kirsten J Ward - kjward@pms.ac.uk; Sian Ellard - S.Ellard@exeter.ac.uk; Chittaranjan S Yajnik - csyajnik@hotmail.com; 
Timothy M Frayling - tim.frayling@pms.ac.uk; Andrew T Hattersley* - A.T.Hattersley@exeter.ac.uk; 
Prathyusha NS Venigalla - prathyu_a@yahoo.com; Giriraj R Chandak - chandakgrc@ccmb.res.in
* Corresponding author    
Abstract
Apolipoprotein AV (ApoAV) gene variant, -1131T>C, is associated with increased triglyceride
concentrations in all ethnic groups studied. An MseI based RFLP analysis is the most commonly
used method for genotyping this SNP. We genotyped a large cohort comprising 1185 Asian Indians
and 173 UK Caucasians for -1131T>C using an ARMS-PCR based tetra-primer method. For quality
control, we re-genotyped approximately 10% random samples from this cohort utilizing the MseI
RFLP, which showed a 2.9% (3/102) genotyping error rate between the two methods. To
investigate further, we sequenced the 900 bp region around the -1131T>C polymorphism in 25
Asian Indians and 15 UK Caucasians and found a number of polymorphisms including the -987C>T
polymorphism. Further analysis of the -987C>T SNP showed a higher rare allele frequency of 0.23
in Asian Indians (n = 158) compared to 0.09 in the UK Caucasians (n = 157). This SNP is located 4
bp from the 3' end of the RFLP forward primer and is in weak linkage disequilibrium with -1131T>C
variant (r2 = 0.084 and D' = 1). Repeated RFLP analysis of seven subjects heterozygous for -987C>T
(seven times), showed discordant results with the sequence at -1131T>C SNP nearly one third (15/
49) of the time. We conclude that presence of -987C>T polymorphism in the forward primer of
the MseI RFLP assay may lead to allelic drop-out and generate unforeseen errors in genotyping the
-1131T>C polymorphism. Our results also emphasise the need for careful quality control in all
molecular genetic studies, particularly while transferring genotyping methods between various
ethnic groups.
Introduction
Apolipoprotein AV is an important regulator of triglycer-
ides concentrations. The ApoAV gene was identified adja-
cent to the Apolipoprotein cluster (consisting of ApoAI,
ApoAIV and ApoCIII genes) [1,2]. The gene encodes a pro-
tein that is thought to be fundamental in the transport of
triglyceride rich lipoproteins from the liver [3]. Its hepatic
expression has been shown to influence post-prandial
triglyceride concentrations [3] and has the potential to act
as an intracellular break in the very low density lipopro-
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tein (VLDL) assembly [4]. In addition, ApoAV also
enhances VLDL metabolism through physical interaction
with lipoprotein lipase [5].
Polymorphisms in APOAV are known to influence the cir-
culating triglyceride concentrations. These variants are
split into 3 common haplotypes, of which 2 are associated
with increased triglyceride concentrations irrespective of
age, gender, ethnicity, pregnancy, lipid profile, and dietary
fat intake and are tagged by two SNPs, -1131T>C and
S19W [1,6-9]. In keeping with this, the prevalence of the
rare allele for these polymorphisms is higher among sub-
jects with diseases associated with a raised triglyceride
concentration such as Familial Hypercholesterolemia,
Familial Combined Hyperlipidaemia and Hypertriglycer-
idaemia [10-15]. The rare allele at -1131T>C polymor-
phism is also associated with increased risk of coronary
heart disease [16-18].
The rare allele frequency varies between different ethnic
groups and populations of Chinese and Japanese descent
have a higher prevalence of the -1131C allele and a lower
prevalence of the W19 allele when compared to Cauca-
sian populations [1,7,8,19,20].
This paper concentrates on a potential pitfall in the most
widely used method (>65% publications) for genotyping
the -1131T>C polymorphism using the abolition of a
restriction site for MseI enzyme [1]. We detected an unac-
ceptable error rate using our standard quality control
checks (a random 10% of samples re-genotyped using a
second method). Investigation of the discordant results
between the RFLP and the tetra-primer methods for geno-
typing -1131T>C polymorphism led to identification of a
polymorphism within the primer binding site of the RFLP
forward primer resulting in allelic drop-out. To alleviate
these problems, we propose alternative methods for gen-
otyping -1131T>C polymorphism in the APOAV gene.
Results
Discordant results in samples typed by two methods
One thousand, one hundred and eighty five Asian Indian
and 173 UK Caucasian subjects were initially genotyped
for the -1131T>C polymorphism using the tetra-primer
ARMS-PCR method. In keeping with our standard labora-
tory protocol, 102 of these subjects were re-genotyped
using the MseI RFLP as a quality control check. In 2.9% (3/
102) of samples the results for the two methods were dis-
cordant. This high rate of discordant samples could not be
explained by sample mix-up or by failed or partial diges-
tion. Sequencing suggested that the erroneous results were
due to the RFLP method.
Polymorphisms present in the primer binding sites
As the discordant results could most plausibly be
explained by allelic drop-out, we sequenced the 900 bp
region covering the primer sequences for both the meth-
ods in 40 subjects (25 Asian Indians and 15 Caucasians).
Sequence analysis identified several polymorphisms (Fig.
1) of which three were located in the primer binding sites
and may potentially alter primer binding. The -987C>T
(rs17120035) polymorphism was situated 4 bp from the
3' end of the forward primer for RFLP analysis (Fig. 2).
Two other polymorphisms were identified in the tetra-
primer inner primer regions; -1108C>G (rs1729411) was
5 bp from the 5' region of the forward primer and a novel
Schematic of the ApoAV gene, its variants and primer positions Figure 1
Schematic of the ApoAV gene, its variants and primer positions.
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SNP -1148G>A that was located 9 bp from the 5' end of
the reverse primer (Fig. 1).
Since no polymorphisms were identified in the region of
the outer primers used for the tetra-primer assay, we used
them for sequencing to assess the prevalence of the iden-
tified polymorphisms in 158 unrelated Asian Indian
adults and 157 unrelated UK Caucasian adults (table 1).
The -987C>T polymorphism located within the RFLP for-
ward primer was fairly common with a rare allele fre-
quency of 0.23 in Asian Indian subjects and 0.09 within
UK Caucasian subjects. While the -1108C>T SNP was not
observed in the Asian Indian subjects and only in the UK
Caucasian subjects (rare allele frequency = 0.10), the -
1148C>T polymorphism situated within the tetra-primer
inner reverse primer was observed in the Asian Indian
samples only (rare allele frequency = 0.01). The polymor-
phisms studied were in Hardy Weinberg Equilibrium
(HWE) and linkage disequilibrium was observed between
-987C>T and -1131T>C both in Asian Indians and UK
Caucasians (D' = 1.00, r2 = 0.084 and D' = 0.998, r2 =
0.001, respectively).
Heterozygosity in the primer polymorphism -987C>T is 
associated with errors in genotyping -1131T>C using the 
RFLP assay
We performed the MseI RFLP assay for -1131T>C on two
separate occasions in 82 Asian Indians of known genotype
(by sequencing the SNP). This showed at least one dis-
cordant result between the sequencing and the RFLP in 13
subjects (14%), with three being discordant on both occa-
sions. Eight of the 13 (62%) discordant samples were het-
erozygous for both the -1131T>C and the -987C>T
polymorphisms compared to 1 of the 69 (1.4%) who did
not show discordant results (p < 0.001). As heterozygosity
at the -987C>T polymorphism was associated with dis-
cordant results, this suggests that this polymorphisms
altered primer binding resulting in allelic drop-out on
RFLP assay for -1131T>C. To substantiate the role of -
987C>T SNP further, we identified 7 subjects hetero-
zygous for both -1131T>C and -987C>T and re-genotyped
them using the RFLP assay 7 times. Results for the RFLP
differed with sequencing (gold standard) results for 15
out of a total of 49 genotypes (31%) with each subject
being discordant on at least one occasion. No individual
showed a genotype that was different from that deter-
Table 1: Rare allele frequencies for the polymorphisms in the ApoAV gene found through initial sequencing
Polymorphism Refseq number Asian Indian UK Caucasian
-798G>A rs10750097 0.27 0.27
-872A>G rs7103224 0.20 0.07
-987C>T rs17120035 0.23 0.09
-1026G>A Not on databases 0.35 0.00
-1108C>G rs4938312 0.00 0.10
-1131T>C rs662799 0.22 0.05
-1148C>T Not on databases 0.01 0.00
-1163C>T rs1729411 0.05 0.02
-1242C>T Not on databases 0.004 0.01
This shows the -987C>T polymorphism which potentially alters primer binding for the RFLP method of genotyping (primer  sequence is placed within the boxed area, with the site of the polymorphism in capital letter) Figure 2
This shows the -987C>T polymorphism which potentially alters primer binding for the RFLP method of genotyping (primer 
sequence is placed within the boxed area, with the site of the polymorphism in capital letter).
5’- tcatacacacgttcacaagctcccgattcttggtcCtaaatgcatcttgaatcaatcccctctcctccatttcca -3’
Primer:
DNA:
3’- cagGatttacgtagaacttagttag -5’
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mined by sequencing on all 7 occasions (range 1/7 – 4/7).
These results suggest that -987C>T SNP causes allelic
drop-out on some but not all occasions.
Discussion
Our study shows that presence of a polymorphism-
987C>T in the ApoAV gene can produce allelic drop-out
resulting in an incorrect genotype at SNP -1131T>C when
genotyping by the widely used MseI RFLP assay. The error
occurs in the background of heterozygosity both at -
987C>T and -1131T>C and only on some occasions on
the same sample. This potential source of error was prob-
ably detected in an Asian Indian cohort because both -
987C>T and -1131T>C are over 3 times more prevalent
than UK Caucasians. There is evidence in the literature
that common polymorphisms within primer binding sites
[21-23] can result in allelic drop-out which may be due to
preferential amplification of one allele or through other
mechanisms [24]. The degree of allelic drop-out may also
result in a relative lack of heterozygous subjects within a
population and deviation from Hardy Weinberg equilib-
rium [23]. Many such polymorphisms are known to be
race-specific [25]. As the majority of data on -1131T>C
exists on European Caucasian subjects with very limited
data available on other ethnic groups such as Asian Indi-
ans and Sub-Saharan Africans, our observations prompt
for more caution while initiating similar analysis in new
populations.
The -987C>T polymorphism is likely to contribute to gen-
otyping error especially in Asian Indian samples if the pre-
viously described primers are used. Therefore it is wise to
use another assay to define the genotype at -1131T>C
such as the ARMS-PCR based tetra-primer assay we used
[9]. This is based on a method first described by Ye et al,
in 2001 [26] with primers designed using the Tetra-primer
ARMS-PCR website[27]. Although we did find SNPs that
are present in primers used in this method, these are con-
siderably less common, are not close to the 3' end of the
primer and no errors were seen compared to sequencing.
Therefore the tetra-primer method is our preferred alter-
native.
We have developed a new restriction assay for the -
1131T>C polymorphism that avoids all known polymor-
phisms in primer binding sites. This uses the tetra-primer
outer forward primer (5'-CAAGGTGACAGACAACTGGT-
GCAATGAT-3') and the RFLP reverse primer (5'-
CCCCAGGAACTGGAGCGAAATT-3') to amplify a frag-
ment of 239 bp. In the presence of the rare C allele, MseI
digestion will result in fragments of 217 bp and 22 bp.
The PCR was performed in 10 µl reactions with standard
reagents using 2.5 mM MgCl2 and 0.5U of Amplitaq Gold
(Applied Biosystems, UK) using cycling conditions as ini-
tial denaturation at 94°C for 12 minutes followed by 40
cycles of denaturation at 94°C for 45 seconds, annealing
at 63°C for 45 seconds and extension at 72°C for 45 sec-
onds, with a final extension of 72°C for 10 minutes. The
MseI digestion was performed as previously described by
Pennacchio et al, 2001 [1]. This new PCR RFLP assay
worked in 96 samples with no discrepancies and no errors
when compared to the original genotyping results for the
tetra-primer assay.
Conclusion
In conclusion, the -987C>T polymorphism is present in
UK Caucasians and Asian Indians and can result in allelic
drop-out within the widely used MseI RFLP assay for gen-
otyping the triglyceride associated polymorphism -
1131T>C. This is especially important in the Asian Indian
population as both -987C>T and -1131T>C polymor-
phisms are more prevalent. Our result stresses the impor-
tance of checking and repeatedly checking SNP databases
for polymorphisms in the primer binding sites (the -
987C>T polymorphism was not reported when we started
out studies on the -1131T>C polymorphism). It also
emphasises the need to use a second genotyping method
as a quality control. This type of check is particularly
important when studying new populations as allele fre-
quencies of the same polymorphism can vary greatly
between populations meaning a primer binding site poly-
morphism may be of much greater significance in some
populations than others.
Materials and methods
Genomic DNA samples from 1185 Asian Indian subjects
from 395 Asian Indian family trios (mother, father and
child) from the Pune Children Study [28,29] and 173
unrelated UK Caucasians from the EFS and Plymouth Ear-
lyBird study [9,30] were initially genotyped for -1131T>C
variant using an ARMS based tetra-primer method. The
design of primers would amplify a control product of 404
bp while the PCR products of 250 bp and 242 bp would
identify T and C alleles respectively.
The primer sequences used are as follows:
Tetra-primer Outer Forward: 5'-CAAGGTGACA-
GACAACTGGTGCAATGAT-3'
Tetra-primer Outer Reverse: 5'-AGCCCCTGAAAGCT-
TCACTACAGGTTCC-3'
Tetra-primer Inner Forward: 5'-TTCAGCTTTTCCTCAT-
GGGGCAAATATC-3'
Tetra-primer Inner Reverse: 5'-GAGCCCCAGGAACT-
GGAGCGAAATTA-3'Lipids in Health and Disease 2006, 5:11 http://www.lipidworld.com/content/5/1/11
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The PCR was performed using cycling conditions of initial
denaturation at 95°C for 2 min, followed by 35 cycles of
denaturation at 95°C for 1 min, annealing at 59°C for 1
min and extension at 72°C for 1 min, with a final 2 min
extension at 72°C. PCR products were run on a 3% agar-
ose gel at 200 V for 90 minutes and scored by two inde-
pendent workers (KW and GRC). Subsequently, ~10% of
these samples (n = 102) were analysed by PCR-RFLP using
2U of MseI enzyme [1] for the quality control check.
In an attempt to investigate the discordant results between
the RFLP based and tetra-primer based genotyping, prim-
ers were designed to amplify a 900 bp region encompass-
ing both tetra-primers and RFLP primers (Fig. 1). Finally,
tetra-primer outer primer pair was utilised as the gold
standard for confirmation of individual sequence since
this region did not show any polymorphism on sequence
analysis of the 900 bp region. All the PCR products were
purified using post-PCR purification plates from Milli-
pore and sequenced individually on both the strands
using Big Dye terminator cycle sequencing ready kit (Ver-
sion 1.1, Applied Biosystems, Warrington, UK) on ABI
3100 Genetic Analyzer (Applied Biosystems).
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